Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Consider benefits and risks of new alopecia treatments for safety.

Current treatments for alopecia show no significant long-term benefits.

Acne is caused by multiple factors including oil production, bacteria, inflammation, and possibly diet and environment.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Natural products like plant extracts can help promote hair growth and could be used to treat hair loss.

The Chinese herbal supplement BeauTop can potentially boost hair growth and thickness by increasing a protein called Vascular Endothelial Growth Factor.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

MMP-2 and MMP-9 help hair grow, while their inhibitors peak when hair growth slows.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Sodium valproate caused vomiting in 20% of children under 2 years old, with other side effects like hair loss and loss of appetite also noted.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Sodium valproate caused vomiting, hair loss, loss of appetite, abdominal pain, weight gain, and anemia in young children with epilepsy.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Yikgeebohyul-tang promotes hair growth and could help treat hair loss.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.